50
Participants
Start Date
May 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Self administration
Subjects will self administer injections of 104 mg of the subcutaneous formulation of depot medroxyprogesterone acetate (depo-subQ provera 104).
Planned Parenthood of Southwest and Central Florida, Tampa
Planned Parenthood of Southwest and Central Florida, Fort Myers
Collaborators (1)
Pfizer
INDUSTRY
Planned Parenthood Federation of America
OTHER
University of North Carolina, Chapel Hill
OTHER